Why is Venus Remedies falling/rising?

As of 28-Jul, Venus Remedies Ltd is currently priced at Rs 513.00, reflecting a decrease of Rs 5.6 or 1.08%. Today's price summary indicates that the stock has underperformed its sector by 1.16%, despite reaching an intraday high of Rs 528.95 earlier in the day. Over the past week, the stock has seen a decline of 5.03%, while it has performed positively over the last month with an increase of 11.76%. The company has reported significant growth in net profit, with a 99.81% increase, and has declared positive results for the last two consecutive quarters. Additionally, institutional investors have increased their stake, indicating growing confidence in the company's fundamentals. In the broader market context, the stock's short-term performance has been relatively weak compared to the benchmark, as it has fallen 5.03% over the past week while the Sensex has only declined by 1.59%. However, on a longer-term basis, Venus Remedies has outperformed the benchmark with a year-to-date return of 62.78% compared to the Sensex's 3.52%. This strong performance over the longer term, coupled with attractive valuations and increasing institutional participation, suggests that while the stock is currently experiencing a decline, its overall trajectory remains positive.